Leukemia, Erythroblastic, Acute
"Leukemia, Erythroblastic, Acute" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
| Descriptor ID |
D004915
|
| MeSH Number(s) |
C04.557.337.539.275.325 C15.378.190.636.276
|
| Concept/Terms |
Leukemia, Erythroblastic, Acute- Leukemia, Erythroblastic, Acute
- Myeloid Leukemia, Acute, M6
- Erythroleukemia
- Erythroleukemias
- Di Guglielmo's Disease
- Di Guglielmos Disease
- Disease, Di Guglielmo's
- Erythremic Myelosis
- Erythremic Myeloses
- Myeloses, Erythremic
- Myelosis, Erythremic
- Erythroblastic Leukemia, Acute
- Acute Erythroblastic Leukemia
- Acute Erythroblastic Leukemias
- Erythroblastic Leukemias, Acute
- Leukemia, Acute Erythroblastic
- Leukemias, Acute Erythroblastic
- Leukemia, Myeloid, Acute, M6
- Di Guglielmo Disease
- Disease, Di Guglielmo
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Erythroblastic, Acute".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Erythroblastic, Acute".
This graph shows the total number of publications written about "Leukemia, Erythroblastic, Acute" by people in this website by year, and whether "Leukemia, Erythroblastic, Acute" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 2 | 3 |
| 1997 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, Erythroblastic, Acute" by people in Profiles.
-
Potent activity against K562 cells by polyamide-seco-CBI conjugates targeting histone H4 genes. Bioorg Med Chem. 2010 Jan 01; 18(1):168-74.
-
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol. 2006 Dec; 135(5):642-50.
-
Evidence that human haematopoietic stem cells (HSC) do not reside within the CD34+KIT- cell population. Ann Transplant. 1999; 4(1):22-30.
-
Distinct signaling from stem cell factor and erythropoietin in HCD57 cells. J Biol Chem. 1997 Mar 14; 272(11):6850-3.
-
Increased expression of the ETS-related transcription factor FLI-1/ERGB correlates with and can induce the megakaryocytic phenotype. Cell Growth Differ. 1996 Nov; 7(11):1525-34.
-
Characterization of the cloned HEL cell thromboxane A2 receptor: evidence that the affinity state can be altered by G alpha 13 and G alpha q. J Pharmacol Exp Ther. 1996 May; 277(2):1132-9.
-
Androstenedione increases thromboxane A2 receptors in human erythroleukemia cells. Life Sci. 1996; 58(8):683-90.
-
Androgen regulation of thromboxane A2 receptors. Adv Prostaglandin Thromboxane Leukot Res. 1995; 23:251-3.
-
Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells. Am J Physiol. 1993 Dec; 265(6 Pt 1):E928-34.
-
The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors. Cell Growth Differ. 1992 Oct; 3(10):705-13.